Member Info for SHAREINTHIS

MIKODX
All well and good but this was on the 8th Nov.
His latest video afterwards,Nov 12th is more interesting as he doesn't seem to think that at current low levels (48p) he sees it as a buy and wants to get out if he makes a slight profit. His rational is the 50p level and may even dip further.

Deano.
I asked for only a few more 200. I've got 1. Yes a whole 1... thank you ITM.

There's also.
https://markets.businessinsider.com/news/stocks/pfizer-ceo-sold-stock-day-covid-19-vaccine-results-unveiled-2020-11-1029790705

Don't know but maybe they won't yet reach 90% on the vaccine and may wait for MHRA approval.
BioNTech have gone down 2.615 at time of writing so not all good news. Surely if this the Vaccine of all vacinnes the the share price should be doing a Synarigen.North,north,north.

Safy.
Can you remind me what NT stands for thanks.

I have shares in BioNTech not a great deal but have been watching them grow steadily,nice.
But they have only gone up 14% on this amazing news. You would of thought they would go up in the same way as Synarigen on this news,100% plus but no 14%. This is the most improtant new this century but the markets haven't reacted like it is for Pfizer or BionTech. Strange times indeed.

spurs
your like my housemate ramping up his same team and ODX for ages
now you've gone the other way

Biffy Boy
I'm furious with HL too, couldn't get in all afternoon.
I'll probably be at the back of the queue.

psmith
you seem like a Southbank Research subscriber ?

Are you talking about
SGJ
@MrGIFFFY
6h
Replying to
@MrGIFFFY

Sorry but I don't know the significance of L&G in the impact to ODX.

Mr Nation
Are you talking about Val "here"
Or some mega Pharma stock ?

Twatcher
I see where you coming from.
Having stayed in India for 9 months and hearing first hand that virtually everyone returning to India during the early days of Covid,taking paracetmol was almost mandatory. So much so that paracetmol was in short supply.

Toneman
Thanks for that.
I was seeeking recent news that may boost the share price.

Sharpeye
I would of thought Toneman could answer that for himself. I was asking why he thought it was worth it. A simple question for the reason I would like to know. I wasn't knocking him in slightest. My top limit was not 300p,read the post properly.I would love it to go back over 360p but for a while I don't think it will under the current economic situation in Europe.If there's news out there that it's going to surge then fill us in .

toneman
,where is your news that this is worth buying x6 your offer ?
It's a good long term hold as I've made profit on the share. But can't see this going much above 300p/

BILBO
I've been in for a year now. Could of sold out at the year high but wanted to stay in as I see this as a long term. Many sellers in the June peak were influenced by Southbank Research. Their advice to sell half your stake then the other half days later sent the price down. All the news to me seems positive but maybe I should of sold at the other times it reached over 300p. Now I'll just have to wait.
Looking like Mr Smith has been wrong today.

I tried buying with a 75p price limit this morning. Rejected.
Open was 71.5. Ridiculous

Don't expect it to all die down until a couple of weeks later.
Lots of counting and re counting to be done

I DMOR on them ,wish I had when I was looking in the early summer when I bought here.
I bought in on Tuesday thinking it was due to the high price. Then Wednesday happended . But I was sure it will go higher.
I've DMOR on ODX and we should be higher. I'm a bit baffled on their PR especially Walbrook tbh.
GLA

Bluelight on NOVACYT BB is gleaming
Anyone else read this point for today's ODX RNS as meaning NCYT has cornered the market? "ODX. Following initial orders for this test, traction has not materialised as the Company was originally anticipating. The Company believes this is due, in part, to competition from ELISA antibody tests that are now available on larger automated instruments and an evolving market need that seems more geared towards lateral flow antibody tests."

Thoughts